Aligos Therapeutics, Inc. SEC filings ALGS
Aligos Therapeutics, Inc. has 348 filings in SEC EDGAR's recent list, going back to Jan 16, 2020. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 6, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 6, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 6, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2026 | Nov 6, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 15, 2026 | Sep 10, 2026 |
| S-8 | Employee stock plan registration | Aug 6, 2026 | — |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 26, 2026 | Jun 25, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 29, 2026 | Jun 25, 2026 |
| 8-K |
Current report
Material agreement
|
Apr 21, 2026 | Apr 16, 2026 |
| 8-K |
Current report
Other events
|
Apr 14, 2026 | Apr 14, 2026 |
| S-8 | Employee stock plan registration | Mar 5, 2026 | — |
| 10-K | Annual report | Mar 5, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 5, 2026 | Mar 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 4, 2026 | Jan 29, 2026 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| S-8 | Employee stock plan registration | Aug 6, 2025 | — |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 26, 2025 | Jun 25, 2025 |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| DEFA14A | Additional proxy material | Apr 28, 2025 | — |
| ARS | Annual report to shareholders | Apr 28, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 28, 2025 | Jun 25, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2025 | Jun 25, 2025 |
| EFFECT | Filing | Apr 3, 2025 | — |
| 424B3 | Prospectus | Apr 3, 2025 | — |
| CORRESP | Letter to the SEC | Apr 1, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 1, 2025 | — |
| S-3 | Shelf registration | Mar 27, 2025 | — |
| S-8 | Employee stock plan registration | Mar 10, 2025 | — |
| 10-K | Annual report | Mar 10, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2025 | Mar 10, 2025 |
| D | Filing | Feb 28, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Feb 12, 2025 | Feb 11, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 3, 2025 | Jan 30, 2025 |
| EFFECT | Filing | Nov 18, 2024 | — |
| CORRESP | Letter to the SEC | Nov 14, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 13, 2024 | — |
| S-8 | Employee stock plan registration | Nov 6, 2024 | — |
| S-3 | Shelf registration | Nov 6, 2024 | — |
| 10-Q | Quarterly report | Nov 6, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Other events
|
Sep 5, 2024 | Sep 3, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Aug 19, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 8, 2024 | Aug 7, 2024 |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 28, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Listing notice
|
May 31, 2024 | May 29, 2024 |
| 8-K |
Current report
Listing notice, Officer or director change
|
May 22, 2024 | May 21, 2024 |
| 8-K |
Current report
Officer or director change
|
May 15, 2024 | May 9, 2024 |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 7, 2024 | May 7, 2024 |
| ARS | Annual report to shareholders | Apr 29, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 27, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2024 | Jun 27, 2024 |
| S-8 | Employee stock plan registration | Mar 12, 2024 | — |
| 10-K | Annual report | Mar 12, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2024 | Mar 12, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 28, 2024 | Feb 27, 2024 |
| SC TO-I/A | Filing | Feb 28, 2024 | — |
| SC TO-I | Filing | Jan 30, 2024 | — |
| SC TO-C | Filing | Jan 25, 2024 | — |
| 8-K |
Current report
Other events
|
Jan 25, 2024 | Jan 25, 2024 |
| 424B3 | Prospectus | Nov 28, 2023 | — |
| EFFECT | Filing | Nov 27, 2023 | — |
| CORRESP | Letter to the SEC | Nov 22, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Nov 22, 2023 | Nov 20, 2023 |
| UPLOAD | Letter from the SEC | Nov 21, 2023 | — |
| S-3 | Shelf registration | Nov 17, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Nov 15, 2023 | Nov 9, 2023 |
| D | Filing | Nov 7, 2023 | — |
| 10-Q | Quarterly report | Nov 2, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 25, 2023 | Oct 23, 2023 |
| 8-K |
Current report
Other events
|
Oct 18, 2023 | Oct 16, 2023 |
| 8-K |
Current report
Listing notice
|
Sep 7, 2023 | Sep 5, 2023 |
| 10-Q | Quarterly report | Aug 3, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Other events
|
Aug 1, 2023 | Jul 31, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jul 25, 2023 | Jul 20, 2023 |
| DEFR14A | Filing | Jun 2, 2023 | — |
| 10-Q | Quarterly report | May 4, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 4, 2023 | May 4, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jul 20, 2023 |
| S-8 | Employee stock plan registration | Mar 9, 2023 | — |
| 10-K | Annual report | Mar 9, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2023 | Mar 9, 2023 |
| UPLOAD | Letter from the SEC | Dec 27, 2022 | — |
| CORRESP | Letter to the SEC | Dec 22, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 8, 2022 | — |
| 10-Q | Quarterly report | Nov 2, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2022 | Nov 2, 2022 |
| 10-Q | Quarterly report | Aug 4, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2022 | Aug 4, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 27, 2022 | Jun 23, 2022 |
| 10-Q | Quarterly report | May 4, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 4, 2022 | May 4, 2022 |
| DEFA14A | Additional proxy material | Apr 29, 2022 | — |
| DEF 14A | Proxy statement | Apr 29, 2022 | Jun 23, 2022 |
| 8-K |
Current report
Other events
|
Mar 30, 2022 | Mar 26, 2022 |
| 8-K |
Current report
Other events
|
Mar 22, 2022 | Mar 22, 2022 |
| S-8 | Employee stock plan registration | Mar 10, 2022 | — |
| 10-K | Annual report | Mar 10, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2022 | Mar 10, 2022 |
| 8-K |
Current report
Other events
|
Jan 6, 2022 | Jan 6, 2022 |
| EFFECT | Filing | Nov 19, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Nov 18, 2021 | Nov 16, 2021 |
| CORRESP | Letter to the SEC | Nov 17, 2021 | — |
| UPLOAD | Letter from the SEC | Nov 15, 2021 | — |
| S-3 | Shelf registration | Nov 4, 2021 | — |
| 10-Q | Quarterly report | Nov 4, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2021 | Nov 4, 2021 |
| 10-Q | Quarterly report | Aug 5, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2021 | Aug 5, 2021 |
| 424B4 | Prospectus | Jul 1, 2021 | — |
| EFFECT | Filing | Jun 30, 2021 | — |
| CORRESP | Letter to the SEC | Jun 28, 2021 | — |
| CORRESP | Letter to the SEC | Jun 28, 2021 | — |
| S-1 | Registration statement | Jun 28, 2021 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2021 | Jun 17, 2021 |
| 8-K/A |
Amended current report
Officer or director change
|
Jun 24, 2021 | Apr 26, 2021 |
| UPLOAD | Letter from the SEC | Jun 10, 2021 | — |
| DRS | Filing | Jun 4, 2021 | — |
| 10-Q | Quarterly report | May 10, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 10, 2021 | May 10, 2021 |
| DEFA14A | Additional proxy material | Apr 27, 2021 | — |
| DEF 14A | Proxy statement | Apr 27, 2021 | Jun 17, 2021 |
| 8-K |
Current report
Officer or director change
|
Apr 27, 2021 | Apr 26, 2021 |
| S-8 | Employee stock plan registration | Mar 23, 2021 | — |
| 10-K | Annual report | Mar 23, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2021 | Mar 23, 2021 |
| 10-Q | Quarterly report | Nov 25, 2020 | Sep 30, 2020 |
| S-8 | Employee stock plan registration | Oct 20, 2020 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Oct 20, 2020 | Oct 20, 2020 |
| 424B4 | Prospectus | Oct 19, 2020 | — |
| EFFECT | Filing | Oct 15, 2020 | — |
| CERT | Filing | Oct 14, 2020 | — |
| CORRESP | Letter to the SEC | Oct 13, 2020 | — |
| CORRESP | Letter to the SEC | Oct 13, 2020 | — |
| 8-A12B | Filing | Oct 13, 2020 | — |
| S-1/A | Amended registration statement | Oct 9, 2020 | — |
| SEC STAFF LETTER | Filing | Oct 5, 2020 | — |
| CORRESP | Letter to the SEC | Oct 2, 2020 | — |
| SEC STAFF LETTER | Filing | Sep 28, 2020 | — |
| CORRESP | Letter to the SEC | Sep 25, 2020 | — |
| S-1 | Registration statement | Sep 25, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 23, 2020 | — |
| DRS | Filing | Aug 26, 2020 | — |
| D | Filing | Jan 16, 2020 | — |
Showing 159 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ALGS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1799448
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.